ALLIANCEBERNSTEIN L.P. - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 111 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q1 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.1%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q1 2021$85,000
+57.4%
43,2000.0%0.00%
Q4 2020$54,000
-66.0%
43,200
-51.1%
0.00%
Q3 2020$159,000
-85.6%
88,300
-33.1%
0.00%
-100.0%
Q2 2020$1,107,000
+60.7%
132,000
+0.4%
0.00%
Q1 2020$689,000
+43.8%
131,500
+49.8%
0.00%
Q4 2019$479,000
+11.9%
87,8000.0%0.00%
Q3 2019$428,000
-29.6%
87,8000.0%0.00%
Q2 2019$608,000
-0.3%
87,8000.0%0.00%
Q1 2019$610,000
+15.5%
87,800
-2.9%
0.00%
Q4 2018$528,000
+26.3%
90,400
+63.2%
0.00%
Q3 2018$418,000
+141.6%
55,400
+61.5%
0.00%
Q2 2018$173,000
+1.8%
34,300
+23.4%
0.00%
Q1 2018$170,000
+57.4%
27,800
+82.9%
0.00%
Q4 2017$108,000
+36.7%
15,200
+38.2%
0.00%
Q3 2017$79,000
+14.5%
11,0000.0%0.00%
Q2 2017$69,00011,0000.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q1 2021
NameSharesValueWeighting ↓
Ikarian Capital, LLC 397,168$43,8880.01%
CJM Wealth Advisers, Ltd. 30,465$3,3660.00%
Tekla Capital Management LLC 154,310$17,0510.00%
McAdam, LLC 10,006$60.00%
Aries Wealth Management 15,400$1,7020.00%
WELLS FARGO & COMPANY/MN 342,084$37,8000.00%
JPMORGAN CHASE & CO 43,415$50.00%
NORTHERN TRUST CORP 207,329$22,9100.00%
PINNACLE ASSOCIATES LTD 18,580$2,0530.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders